As interest in the application of plasma medicine — the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems — continues to grow, so does the need for research advancements proving its capabilities and potential impacts on the health care industry.
Across the world, many research groups are investigating plasma medicine for applications including cancer treatment and the accelerated healing of chronic wounds, among others.
Researchers from Penn State’s College of Engineering, College of Agricultural Sciences and College of Medicine say direct LTP treatment and plasma-activated media are effective treatments against bacteria found in liquid cultures. The researchers also say they have devised a unique way to create plasma directly in liquids.
The team, comprised of engineers, physicists, veterinary and biomedical scientists and medical professionals, is using an atmospheric-pressure plasma jet to use room temperature — “cold” — plasma to treat bacteria.
Plasma, the fourth state of matter, is typically very hot — thousands to millions of degrees. By using plasma generated at atmospheric pressure or in liquids, the researchers can create molecules and atoms with antibacterial effects without burning anything. Sean Knecht, assistant teaching professor of engineering design at Penn State and leader of the Cross-disciplinary Laboratory for Integrated Plasma Science and Engineering, said this process creates many different types of reactive particles, making the likelihood of bacterial mutations to simultaneously combat all the particles almost nonexistent.
Knecht explained that the team’s research results, published in Scientific Reports, show that plasma technology generates large amounts of reactive oxygen species or reactive particles created from molecules that contain oxygen atoms, including oxygen molecules in the air and water vapor. The plasma’s effect on different bacteria such as E. coli and Staph. aureus is significant, resulting in many bacterial deaths through multiple generations.
“Over the course of four generations of bacteria, these bacteria do not acquire any form of resistance to the plasma treatment,” he said.
Girish Kirimanjeswara, associate professor of veterinary and biomedical sciences at Penn State, said this is extremely important due to the typical way bacteria mutate, making them resistant to antibiotics.
Antibiotics target a specific metabolic pathway, essential protein or nucleic acids in bacteria. Because of this, antibiotics have to enter a bacterial cell to find and bind to that specific target. Any bacterial mutation that decreases an antibiotic’s entry capabilities or increases its rate of exit makes the antibiotic less effective. Mutations happen naturally at a low rate but can rapidly accumulate by selection pressure when introduced to antibiotics aimed at fighting the bacteria.
According to Kirimanjeswara, the team’s research results show that plasma treatment produces various reactive oxygen species at a concentration high enough to kill bacteria, but low enough to not have negative impacts on human cells. He explained that the oxygen species quickly target virtually every part of the bacteria including proteins, lipids and nucleic acids.
“One can call it a sledgehammer approach,” Kirimanjeswara said. “It is difficult to develop resistance by any single mutation or even by a bunch of mutations.”
The team also applied these findings to design a system that can create plasma directly in liquids. The researchers intend to create plasma in blood to address cardiovascular infections directly at the source. To do so, high electric voltage and large electric currents are typically used. In the plasma system created by the researchers, the electrical current and energy that might reach the patient are minimized by using dielectric, or electrically-insulating, materials. Materials that the team would typically use to create the plasma include glass and ceramic due to their capability to withstand high local temperatures. These materials tend to make blood clot and may not be very flexible, a necessity if they are to be used in the cardiovascular system. The team is investigating insulating coatings that are biocompatible, or acceptable by the human body, and flexible. Knecht said the team has identified a polymer called Parylene-C and reported the initial results in the journal IEEE Transactions on Radiation and Plasma Medical Sciences. The team is further pursuing this avenue, as polymers have low melting points and may not withstand repeated exposure to plasma.
“Biocompatible polymers can be used for plasma generation in biological liquids, but their lifetime is limited,” Knecht said. “New unique plasma generation designs must be developed to produce lower intensity plasma discharges that can extend their lifetime. That is what we are continuing to work on.”
Kirimanjeswara said scientists typically work to understand how different bacteria cause disease or how host immune responses eliminate bacteria to create new antibiotics and vaccines. Though these more traditional approaches are essential, they are often gradual and time-consuming. The team’s innovative research highlights the importance of continuing to investigate new ways to combat bacteria.
“Transformative and cross-disciplinary approaches have the potential to speed up finding solutions to urgent global problems,” he said. “It is important for the general public to be aware of and appreciate the fact that the scientific community is engaged in several approaches, some traditional and others nontraditional, to combat the growing problem of antibiotic resistance. We hope our research reinforces the idea of embracing nonantibiotic approaches to treat bacterial infections in the future.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Characterizing SARS-CoV-2 convalescent plasmaon June 22, 2020 at 9:05 pm
A new study published on the preprint server bioRxiv in June 2020 uses serologic correlates to assess the efficacy of convalescent plasma. This will also help to classify donor plasma as more or less ...
- Those who have recovered from COVID-19 can donate plasmaon June 22, 2020 at 3:41 pm
For a month now the local plasma center has been accepting convalescent donations from those that have recovered from COVID-19.
- Experts rule against plasma, Dexamethasone, Actemra as viable COVID-19 cureson June 22, 2020 at 8:33 am
Coronavirus expert advisory panel has rule against blood plasma transfusion and administration of Dexamethasone as viable cures of the infection ...
- Illinois Man Survives Lung Transplant with Coronavirus Plasmaon June 18, 2020 at 4:02 pm
After Edgardo Diaz, an emergency medical technician, tested positive for COVID-19, doctors monitored him closely. When his kidneys began failing, he was hospitalized. Doctors were able to give him ...
- Supply for effective plasma treatment dwindles as Sarasota and Manatee see uptick in COVID-19 caseson June 18, 2020 at 2:59 pm
We realize the pandemic that we are in is a marathon,” said SMH President and CEO David Verinder. “We’ve known that all along, but we certainly are experiencing it.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Rare, super coronavirus antibodies likely to yield vaccine, say Stanford, UCSF expertson June 19, 2020 at 7:55 pm
A super-strength antibody that attacks the destructive spike proteins in the coronavirus is one of many recent discoveries by scientists in laboratories, hospitals and universities searching for a way ...
- A simple face mask can battle COVID-19 & keep California’s economy opening upon June 19, 2020 at 12:56 am
California is now requiring that face masks be worn in inside public places and in a number of outdoor situations. Those revolted at the idea need to read the fine print. The parameters are more than ...
- Californians required to cover their faces in ‘most settings outside the home’on June 18, 2020 at 9:31 pm
California’s health department announced Thursday that the state’s roughly 40 million residents must cover their faces in “most settings outside the home." California embraced especially strict ...
- Certain patients who receive hospital care for COVID-19 exhibit clear signs of brain injuryon June 18, 2020 at 3:45 pm
Some people infected with the coronavirus SARS-CoV-2 get only mild, cold-like symptoms, while others become severely ... but which leaks out into the blood if they are damaged. Elevated plasma NfL ...
- Evidence of radial Weibel instability in relativistic intensity laser-plasma interactions inside a sub-micron thick liquid targeton June 18, 2020 at 2:37 am
In particular, when a relativistic intense laser focus interacts with a thin solid density target, ionized electrons are accelerated to near the speed of light (c) within an optical cycle and are ...